Differential Effects of DHA- and EPA-Rich Oils on Sleep in Healthy Young Adults: A Randomized Controlled Trial
Authors:
- Michael J. PatanMPMichael J. Patan
- David O. KennedyDKDavid O. Kennedy
- Cathrine HusbergCHCathrine Husberg
- Svein Olaf HustvedtSHSvein Olaf Hustvedt
- Philip C. CalderPCPhilip C. Calder
- Benita MiddletonBMBenita Middleton
- Julie KhanJKJulie Khan
- Joanne ForsterJFJoanne Forster
- Philippa A. JacksonPJPhilippa A. Jackson
Open Access
Abstract
Emerging evidence suggests that adequate intake of omega-3 polyunsaturated fatty acids (n-3 PUFAs), which include docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), might be associated with better sleep quality. N-3 PUFAs, which must be acquired from dietary sources, are typically consumed at suboptimal levels in Western diets. Therefore, the current placebo-controlled, double-blind, randomized trial, investigated the effects of an oil rich in either DHA or EPA on sleep quality in healthy adults who habitually consumed low amounts of oily fish. Eighty-four participants aged 25–49 years completed the 26-week intervention trial. Compared to placebo, improvements in actigraphy sleep efficiency (p = 0.030) and latency (p = 0.026) were observed following the DHA-rich oil. However, these participants also reported feeling less energetic compared to the placebo (p = 0.041), and less rested (p = 0.017), and there was a trend towards feeling less ready to perform (p = 0.075) than those given EPA-rich oil. A trend towards improved sleep efficiency was identified in the EPA-rich group compared to placebo (p = 0.087), along with a significant decrease in both total time in bed (p = 0.032) and total sleep time (p = 0.019) compared to the DHA-rich oil. No significant effects of either treatment were identified for urinary excretion of the major melatonin metabolite 6-sulfatoxymelatonin. This study was the first to demonstrate some positive effects of dietary supplementation with n-3 PUFAs in healthy adult normal sleepers, and provides novel evidence showing the differential effects of n-3 PUFA supplements rich in either DHA or EPA. Further investigation into the mechanisms underpinning these observations including the effects of n-3 PUFAs on sleep architecture are required.Keywords
Funding Information
- BASF (Norway) (CTN00716203)
This publication has 44 references indexed in Scilit:
- Association between sleep disorders, obesity, and exercise: a reviewNature and Science of Sleep, 2013
- Independent associations between fatty acids and sleep quality among obese patients with obstructive sleep apnoea syndromeJournal of Sleep Research, 2013
- Five-Year Follow-up of Harms and Benefits of Behavioral Infant Sleep Intervention: Randomized TrialPediatrics, 2012
- (Mis)perception of sleep in insomnia: A puzzle and a resolution.Psychological Bulletin, 2012
- Serotonin control of sleep-wake behaviorSleep Medicine Reviews, 2011
- Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functionsNature Neuroscience, 2011
- Sleep disturbance and melatonin levels following traumatic brain injuryNeurology, 2010
- Measuring the error in sleep estimation in normal subjects and in patients with insomniaJournal of Sleep Research, 2010
- Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patientsJournal of Sleep Research, 2008
- Obesity‐induced inflammation: a metabolic dialogue in the language of inflammationJournal of Internal Medicine, 2007